When was Hiro Science founded?

Hiro Science was founded in 2024.

Where is Hiro Science located?

Hiro Science is headquartered in Stateline, United States.

Where does Hiro Science rank among its competitors?

Hiro Science ranks 28th amongst 28 active competitors, of which 9 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Array Patch, which secured $1.8M in Nov, 2026.

Who are the top competitors of Hiro Science?

Hiro Science's top competitors include Insulet, Micron Biomedical and Enable Injections. Among them, Array Patch secured the most recent funding round in November, 2026.

Hiro Science - 2026 Company Profile, Funding & Competitors

Company Details

Developer of transdermal patch systems featuring dissolvable microneedle delivery technology. This organization produces medical delivery solutions designed for the timed release of peptides and small molecule compounds. By utilizing precise, dissolvable microneedles, these patches serve as an injection-free alternative for various research and therapeutic applications. The entity focuses on developing thermally stable delivery platforms to support scientific and medical research requirements.

Website: hiroscience.com
Social

Key Metrics

Founded Year

2024

Location

Stateline, United States

Stage

Funding Raised

Investors

Everywhere

Ranked

28^th among 28 active competitors

Similar Companies

Insulet & 27 more

View Hiro Science's full profile

Hiro Science is a funded company. Hiro Science has 1 institutional investor.

View details of Hiro Science's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Hiro Science include Insulet, Micron Biomedical and Enable Injections. Here is the list of Top 10 competitors of Hiro Science, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Insulet 2000, Boston (United States), Public	Manufacturer of wearable, tubeless insulin delivery systems for diabetes management	$120M	Federated Hermes, Piper Jaffray & 14 others	75/100
2nd	Micron Biomedical 2014, Atlanta (United States), Series A	Developer of microneedle patch technology for vaccines and drugs delivery	$33M	Global Health Investment, J2 Ventures & 10 others	62/100
3rd	Enable Injections 2010, Cincinnati (United States), Series C	Provider of a wearable drug delivery solution	$334M	Sanofi, Magnetar & 13 others	62/100
4th	Array Patch 2024, Dublin (Ireland), Seed	Developer of microneedle patch technology for targeted drug delivery applications	$3.7M	Lakesidecapital, Boole Angel Investment Syndicate ... & 5 others	45/100
5th	Zosano Pharma 2006, Fremont (United States), Deadpooled	Developer of transdermal drug delivery systems for a broad range of therapeutic indications	$147M	Nomura, ProQuest Investments & 9 others	45/100
6th	Terrestrial 2011, Woburn (United States), Series C	Developer of a microarray patch platform for therapeutic delivery	$57.3M	RA Capital Management, Engine Ventures & 2 others	39/100
7th	Raphas 2006, Seoul (South Korea), Public	Developer of microneedle technology for cosmetics and medical applications	-	L&S Venture Capital, NHN Investment & 5 others	35/100
8th	MNS 2022, Leeds (United Kingdom), Seed	Developer of microneedle patch technology for medication delivery and vaccinations	-	Cambridge Angels, Pioneer Group & 2 others	35/100
9th	SkinJect 2015, Pittsburgh (United States), Series A	Developer of microneedle patch to treat skin cancer	$2.5M	Topanga Partners, Velocity Fund Partners	35/100
10th	Innovodigm 2018, Kolkata (India), Seed	Developer of vaccine delivery devices	$635K	IAN Group, BIRAC & 1 others	32/100
28th	Hiro Science 2024, Stateline (United States), Funding Raised	Developer of transdermal patch systems featuring dissolvable microneedle delivery technology	-	Everywhere	15/100